ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
73 hedge funds and large institutions have $142M invested in Anthera Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less call options, than puts
Call options by funds: $1.2M | Put options by funds: $1.31M
Holders
73
Holding in Top 10
1
Calls
$1.2M
Puts
$1.31M
Top Buyers
| 1 | +$7.57M | |
| 2 | +$2.9M | |
| 3 | +$2.72M | |
| 4 |
SCM
Sio Capital Management
New York
|
+$2.05M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$1.89M |
Top Sellers
| 1 | -$9.05M | |
| 2 | -$3.46M | |
| 3 | -$3.02M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1M |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$704K |